Abstract：【Objective】 To investigate the correlation between CD4+ T cells, CD4+ CD25+ regulatory T cells, inflammatory factors and hyperthyroidism liver function injury.【Methods】 The clinical data of 132 patients with hyperthyroidism in our hospital from January 2015 to March 2018 were selected, including 70 patients with liver function injury (observation group) and 62 patients with normal liver function (control group). The levels of CD4+ T cells and CD4+ CD25+ regulatory T cells were detected and compared between the two groups. The serum levels of interleukin-6 (IL-6), interleukin-10 (IL-10), thyroid stimulating hormone (TSH), triiodothyronine (T3) and tetraiodothyronine (T4) were compared between the two groups.【Results】 The level of T3 and T4 in the observation group was significantly higher than that in the control group (P<0.05); there was no significant difference in TSH level between the observation group and the control group (P>0.05). The levels of serum IL-6 and IL-10 in the observation group were significantly higher than those in the control group (P<0.05); the levels of CD4+ T cells and CD4+ CD25+ regulatory T cells in the observation group were significantly lower than those in the control group (P<0.05). ALT and AST were (104.38±32.10) U/L and (90.03±24.39) U/L, respectively, ALP was (82.2±17.44) U/L; Pearson correlation analysis of T lymphocytes, inflammatory factors and ALT, AST, ALP and thyroid hormone levels showed that CD4+ CD25+ regulatory T cells were negatively correlated with ALT, AST, ALP, T3 and T4 (r=-0.544, -0.434,-0.414, -0.322, -0.303, all P<0.05).【Conclusion】 The levels of serum IL-6 and IL-10 increased significantly, while the levels of CD4+ T cells and CD4+ CD25+ regulatory T cells decreased significantly in patients with hyperthyroid liver function injury. Meanwhile, the changes of T lymphocyte subsets are closely related to liver function and thyroid hormone levels.
李前进, 董永辉, 赵福岩. T淋巴细胞及炎症因子水平变化与甲亢性肝损害相关性分析[J]. 医学临床研究, 2020, 37(8): 1220-1222.
LI Qian-jin, DONG Yong-hui, ZHAO Fu-yan. Correlation between Changes of T Lymphocyte and Inflammatory Factors and Hyperthyroidism Liver Damage. JOURNAL OF CLINICAL RESEARCH, 2020, 37(8): 1220-1222.
[1] Aktas G, Sit M, Dikbas O, et al. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis[J].Rev Assoc Med Bras,2017,63(12):1065-1068. [2] Bilge M, Yesilova A, Adas M, et al. Neutrophil- and platelet- to lymphocyte ratio in patients with euthyroid hashimoto’s thyroiditis[J].Exp Clin Endocrinol Diabetes,2018,35(6):90-93. [3] 高海波,张雅微,胡建康,等. IL-2和IL-6水平对Graves病患者131碘治疗预后的影响[J].华中科技大学学报(医学版),2016,45(6):716-718. [4] 曾小红,贺恰仁,陈玉杰,等. CD8＋T细胞异常表达与不同证型甲状腺功能亢进症的相关性研究[J].广州中医药大学学报,2015,32(2):194-198. [5] 宋怀东. 弥漫性甲状腺肿伴甲状腺功能亢进症致病易感基因识别鉴定研究的现状[J].中华内分泌代谢杂志,2011,27(12):961-966. [6] 腾卫平,曾正陪,李光伟.中国甲状腺疾病诊治指南—甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. [7] 陈赟,马维青,何瑶,等. Graves病患者并发甲亢性肝功能损害的临床特征及相关因素分析[J].江苏医药,2017,43(21):1522-1525. [7] 李志伟,王著军,徐旭,等. TNF-α、LPS、IL-6在重症胸腹伤后急性肝损害中的作用[J].中华全科医学,2015,13(1):157-159. [9] 苏国爱,王秋艳,李亚兰,等. IL-2、IL-6和TGF-β在老年甲状腺肿并甲亢患者体内表达水平及其临床意义[J].中国地方病防治杂志,2016,31(4):391-395. [10] 卢亚敏,张明明,李天沛. 老年甲亢性肝损害患者炎症因子的变化及意义[J].中国老年学杂志,2016,36(20):5036-5037.
2020, Vol. 37 
